Email this article Prophylaxis and treatment of congestion in pregnant women
- Authors: Sokolova MY.1
-
Affiliations:
- Перинатальный медицинский центр, Москва
- Issue: Vol 15, No 1 (2013)
- Pages: 66-70
- Section: Articles
- URL: https://journals.rcsi.science/2079-5831/article/view/28195
- ID: 28195
Cite item
Full Text
Abstract
Congestion is one of the most actual problems of modern society. It is known that every second person suffers from congestion in developed counties of the world, hereby women – almost 2 times more frequently in comparison with men. One of the factors which promote congestions is pregnancy and postpartum period. Almost all gynecologists and 50% of pregnant women are aware of the problem. Colon dyskinesia is detected in 115 from 200 pregnant women. Such large rates of the disorder in pregnant women are associated with physiological shifts in digestive system and alterations of its regulation throughout gestation period. The regular nutrition and adequate physical activity play the main role in prevention of congestions during pregnancy. The awareness of women of rational approaches to congestion therapy is also rather important.
Full Text
##article.viewOnOriginalSite##About the authors
M Yu Sokolova
Перинатальный медицинский центр, Москвад-р мед. наук, проф., рук. службы экстрагенитальной патологии
References
- Ивашкин В.Т., Комаров Ф.И., Рапопорт С.И. Краткое руководство по гастроэнтерологии. М.: М-Вести, 2001.
- Парфенов А.И. Понос и запор. Клин. мед. 1997; 3: 53–60.
- Парфенов А.И. Профилактика и лечение запоров у беременных. Гинекология. 2002; 4 (3): 14–7.
- Подзолкова Н.М., Назарова С.В. Транзипег: новые возможности лечения толстокишечного стаза у беременных. Гинекология. 2004; 6 (6): 22–7.
- Шехтман М.М. Руководство по экстрагенитальной патологии. М.: Триада-Х, 2002.
- Dukas L, Willett W, Giovannucci E. Association between physical activity, fiber intake, and other lifestyle variables and consipation in a study of women. Am J Gastroenterol 2003; 98: 1790–6.
- Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003; 349: 1360–8.
- Paille F et al. An open six - month study of the safety of Transipeg for treating constipation in community medicine. J Clin Res 1999; 2: 65–76.
- Talley N. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroentero. Disord 2004; 4 (Suppl. 2): S3–S10.
- Tramonte S, Brand M, Mulrow C et al. The treatment of chronic constipation in adults. A systematic review. J Gen Intern Med 1997; 12 (1): 15–24.
- Tytgat G, Heading R, Muller-Lissner M et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther 2003; 18: 291–301.
- Voskuijl W, de Lorijn F, Verwijs W et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004; 53 (11): 1590–4.
Supplementary files
